Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving genetic counseling for at-risk relatives of cancer patients

Official title: Family HOPE Study (Hereditary Lynch Syndrome Opportunities for Participation &Amp; Engagement)

Run by City of Hope Medical Center · NCT05772130 · Data updated 2026-11-12

This study is testing if talking directly with a healthcare provider about genetic testing results can help at-risk family members of cancer patients get tested more often and feel better about it.

More Malignant Solid Neoplasm trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment240 (estimated)
SponsorCity of Hope Medical Center
Academic / other
Locations1 site (Duarte, California)
StatusRecruiting
StartedMarch 10, 2023
Main results expectedDecember 21, 2026
Study endsDecember 21, 2026
Registry record updatedOctober 16, 2026
Trial IDNCT05772130 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include cancer patients with a pathogenic germline variant who have at least two first-degree relatives eligible for genetic testing.

Probably not a fit

Patients without a pathogenic germline variant or those who do not have at least two at-risk first-degree relatives may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates whether provider-mediated communication of genetic testing results can enhance genetic counseling and testing rates among at-risk relatives of cancer patients. Participants are randomized into two groups: one receives a family letter and genomic test report, while the other receives the same materials along with direct provider contact to discuss the genetic results. The study aims to improve cascade testing rates and assess the psychosocial impact of this communication method. It targets individuals with inherited cancer risk due to pathogenic gene variants.

Why it matters

Potential benefit: If successful, this approach could significantly increase awareness and access to genetic testing for at-risk family members, leading to earlier detection and prevention of cancer.

How similar studies have gone: Other studies have shown success with similar provider-mediated communication approaches in improving genetic counseling and testing rates.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* PATIENTS: Enrolled in City of Hope (COH) institutional review board (IRB) 07047 or have been seen by COH Genetics for genetic testing
* PATIENTS: Have an pathogenic/ likely pathogenic germline variant
* PATIENTS: Fluent in English
* PATIENTS: Age \>= 18 years
* PATIENTS: Willing to provide contact information for eligible first-degree relatives
* PATIENTS: \>= 2 first-degree relatives that are eligible for genetic testing and reside in the United States of America
* FIRST-DEGREE RELATIVES: Proband is a COH patient and has consented to this study
* FIRST-DEGREE RELATIVES: First-degree relative of proband
* FIRST-DEGREE RELATIVES: Resides within the United States
* FIRST-DEGREE RELATIVES: Has not undergone genetic testing for the known familial variant
* FIRST-DEGREE RELATIVES: Are fluent in English
* FIRST-DEGREE RELATIVES: Age \>= 18 years

Exclusion Criteria:

* PATIENTS: Unable to provide informed consent
* PATIENTS: =\< 2 at-risk first-degree relatives who are eligible for genetic testing and/or reside within the United States
* PATIENTS: Unwilling to provide contact information for family members
* FIRST-DEGREE RELATIVES: Unable or unwilling to provide informed consent
* FIRST-DEGREE RELATIVES: Have undergone genetic testing for the known familial variant
* FIRST-DEGREE RELATIVES: Resides outside of the United States

Where it's running

  • City of Hope Medical Center
    Duarte, California, United States
    Recruiting

Study contacts

  • Principal investigator: Stacy W Gray — City of Hope Medical Center

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.